or
forgot password
  • cancer clinical trials in stamford, CT

  • Nutrition Intervention in Treating Women With Breast Cancer
    Bennett Cancer Center
    Stamford, Connecticut 06902
    Breast Cancer
    Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Breast Cancer, Osteoporosis
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Colorectal Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Hematology/Oncology PC/Carl and Dorothy Bennet Cancer Center
    Stamford, Connecticut 06902
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Stamford Hospital
    Stamford, Connecticut 06904
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Stamford Hospital
    Stamford, Connecticut 06904
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Hematology Oncology PC / Bennett Cancer Center
    Stamford, Connecticut 06902
    Breast Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Breast Cancer, Fatigue, Sleep Disorders
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Hematology Oncology P.C.
    Stamford, Connecticut 06902-3628
    Breast Cancer
    Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Non Small Cell Lung Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Hematology Oncology P.C.
    Stamford, Connecticut 06902-3628
    Ovarian Cancer
    Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
    Hematology Oncology PC
    Stamford, Connecticut 06902
    Metastatic Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Ovarian Cancer, Sarcoma
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Colorectal Cancer, Precancerous Condition
    MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
    Medical Oncology Hematology, Stamford Hospital
    Stamford, Connecticut 06902
    Advanced Nonhematological Malignancies, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma, Gastroesophageal Adenocarcinoma
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Pancreatic Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    Hematology Oncology, PC
    Stamford, Connecticut 06902
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Head and Neck Neoplasms
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Breast Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Stamford Hospital
    Stamford, Connecticut 06904
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Participants Who Received Prior First Line Platinum Based Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Non Small Cell Lung Cancer
    A Study in Second Line Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Colorectal Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Stamford Hospital
    Stamford, Connecticut 06904
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Hematology Oncology Associates, P.C.
    Stamford, Connecticut 06902-3628
    Adenocarcinoma of the Lung
    A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
    Hematology Oncology, P.C.
    Stamford, Connecticut 06902
    Sickle Cell Disease
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Stamford Hospital
    Stamford, Connecticut 06904
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Carcinoma of Urinary Tract, Urethral Carcinoma, Carcinoma of Ureter, Carcinoma of Renal Pelvis
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    The Stamford Hospital
    Stamford, Connecticut 06902
    Advanced Prostate Cancer, Prostatic Neoplasms
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Metastatic Clear Cell Renal Cell Carcinoma
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    Carl and Dorothy Bennett Cancer Center
    Stamford, Connecticut 06902-3628
    Multiple Myeloma
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Hematology Oncology Associates, PC
    Stamford, Connecticut 06902
    Pancreatic Cancer
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Stamford Hospital
    Stamford, Connecticut 06904
    Breast Cancer
    Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
    Stamford Hospital, Bennett Cancer Center
    Stamford, Connecticut 06904
    HER2 Negative Breast Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    The Stamford Hospital
    Stamford, Connecticut 06902
    Colorectal Cancer
    A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Neoplasms, Hematologic
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Stamford Therapeutics Consortium

    Trial Locations
    Stamford Therapeutics Consortium
    Cardiology Associates of Fairfield County
    Obesity, Overweight
    A Moderate to Severe Rheumatoid Arthritis Study
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Rheumatoid Arthritis
    Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Bennett Cancer Center
    Stamford, Connecticut 06902
    Lung Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Melanoma (Skin)
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Hematology Oncology, P.C.
    Stamford, Connecticut 06902
    Breast Cancer
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Prostate Cancer
    Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
    Bennett Cancer Center
    Stamford, Connecticut 06902
    Unspecified Adult Solid Tumor, Protocol Specific
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    Carl and Dorothy Bennett Cancer Center
    Stamford, Connecticut 06902-3628
    Pancreatic Cancer
    Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Prostate Cancer
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Hematology Oncology, P.C.
    Stamford, Connecticut 06902
    Ovarian Neoplasms
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Carl and Dorothy Bennett Cancer Center at Stamford Hospital
    Stamford, Connecticut 06904
    Pancreatic Cancer
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    Hematology Oncology, P.C. Carl and Dorothy Bennett Cancer Center
    Stamford, Connecticut 06902-3628
    Non-Hodgkin's Lymphoma
    A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma
    Bennett Cancer Center
    Stamford, Connecticut 06902
    Renal Cell Carcinoma, Metastases
    STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
    Hematology Oncology P.C.
    Stamford, Connecticut 06902-3628
    Melanoma
    GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
    Carl & Dorothy Bennett Cancer Center
    Stamford, Connecticut 06902
    Prostate Cancer